Colt CZ Group (CZG) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
13 Jun, 2025Executive summary
Revenues for 9M 2024 reached CZK 14.97 billion, up 51% year-over-year, driven by the Sellier & Bellot acquisition and strong military/law enforcement and ammunition sales.
Adjusted EBITDA rose 56.1% to CZK 3,021 million, but adjusted net profit declined 12.8% to CZK 1,293 million due to higher financing costs and one-off adjustments.
Net profit for the period was CZK 708.7 million, down from CZK 1.54 billion, impacted by higher interest expenses and acquisition costs.
Q3 2024 was the strongest third quarter ever, with organic firearms revenue up 23% and total units sold up 3.2%.
Major strategic acquisition of Sellier & Bellot completed in May 2024, expanding the ammunition business and geographic reach.
Financial highlights
Adjusted EPS for 9M 2024 was CZK 29, down 32.1% year-over-year, impacted by stock dilution and S&B acquisition-related amortization.
Operating profit was CZK 1.24 billion, up from CZK 1.12 billion year-over-year.
Basic and diluted EPS dropped to CZK 16 from CZK 44 year-over-year.
Cash flow from operating activities rose to CZK 1.41 billion from CZK 642 million year-over-year.
Adjusted EBITDA margin improved, with one-off items including ESOP costs, S&B inventory step-up, and acquisition-related expenses.
Outlook and guidance
FY 2024 guidance confirmed: revenues expected at CZK 20–22 billion (post S&B consolidation), adjusted EBITDA at CZK 4.3–4.7 billion.
Q4 2024 anticipated to be stronger than Q3, with continued positive effects from S&B acquisition.
Management expects continued integration of Sellier & Bellot to drive future synergies and growth.
No indication of impairment for goodwill or intangible assets; assumptions remain unchanged.
Latest events from Colt CZ Group
- Net profit surged as ammunition growth offset U.S. firearms weakness; 2026 set for major gains.CZG
Q4 202525 Mar 2026 - Revenue and net profit surged, with acquisitions and bond issuance fueling future growth.CZG
Q3 202520 Nov 2025 - Ammunition-led growth and acquisitions drove higher revenues, with 2025 outlook reaffirmed.CZG
Q2 202518 Sep 2025 - Record H1 2024 revenue and EBITDA growth driven by Sellier & Bellot acquisition and US recovery.CZG
Q2 202413 Jun 2025 - Q1 2025 revenue up 50% and profit up 73%, with U.S. tariffs posing EBITDA risk.CZG
Q1 20259 Jun 2025 - 2024 revenue up 50.6% to CZK 22.4bn, with 2025 growth and profit distribution split expected.CZG
Q4 20249 Jun 2025